Retroviral gene therapy: Difference between revisions
No edit summary |
No edit summary |
||
Line 20: | Line 20: | ||
Sample citations: <ref name=aa>[https://www.sciencedirect.com/science/article/pii/S016777999901416X?via%3Dihub=Mountain, Andrew. "Gene therapy: the first decade." Trends in biotechnology 18, no. 3 (2000): 119-128.]</ref> | Sample citations: <ref name=aa>[https://www.sciencedirect.com/science/article/pii/S016777999901416X?via%3Dihub=Mountain, Andrew. "Gene therapy: the first decade." Trends in biotechnology 18, no. 3 (2000): 119-128.]</ref> | ||
<ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847443/ Bartlett et al.: Oncolytcaor viruses as therapeutic cancer vaccines. Molecular Cancer 2013 12:103.]</ref> | <ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847443/ Bartlett et al.: Oncolytcaor viruses as therapeutic cancer vaccines. Molecular Cancer 2013 12:103.]</ref> | ||
<br><br>A citation code consists of a hyperlinked reference within "ref" begin and end codes. | <br><br>A citation code consists of a hyperlinked reference within "ref" begin and end codes. | ||
<br>To repeat the citation for other statements, the reference needs to have a names: "<ref name=aa>" | <br>To repeat the citation for other statements, the reference needs to have a names: "<ref name=aa>" | ||
Line 29: | Line 30: | ||
==Section 2== | ==Section 2== | ||
<br> | <br> | ||
<ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847443/ Bartlett et al.: Oncolytcaor viruses as therapeutic cancer vaccines. Molecular Cancer 2013 12:103.]< | <ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847443/ Bartlett et al.: Oncolytcaor viruses as therapeutic cancer vaccines. Molecular Cancer 2013 12:103.]<ref> | ||
<br> | <br> |
Revision as of 01:59, 19 April 2022
Section
By
At right is a sample image insertion. It works for any image uploaded anywhere to MicrobeWiki.
The insertion code consists of:
Double brackets: [[
Filename: PHIL_1181_lores.jpg
Thumbnail status: |thumb|
Pixel size: |300px|
Placement on page: |right|
Legend/credit: Electron micrograph of the Ebola Zaire virus. This was the first photo ever taken of the virus, on 10/13/1976. By Dr. F.A. Murphy, now at U.C. Davis, then at the CDC. Every image requires a link to the source.
Closed double brackets: ]]
Other examples:
Bold
Italic
Subscript: H2O
Superscript: Fe3+
A citation code consists of a hyperlinked reference within "ref" begin and end codes.
To repeat the citation for other statements, the reference needs to have a names: "<ref name=aa>"
The repeated citation works like this, with a forward slash.[1]
Introduction to Retrovirus Gene Therapy
Retroviral therapy is the use of retroviral vectors to provide remedy to disease via the genetic modification of a patient’s own cells. Retroviral vectors are themselves derived from natural retroviruses such as HIV. The name retrovirus refers to the unique ability of these viruses to convert viral RNA into DNA. A critical part of the viral life cycle is the integration of this viral DNA into the host cell’s genome, conferring a permanent genetic change to the cell. Therefore, retroviruses may be used as a vector for gene therapy, a method of treatment dealing specifically with the alteration of genes to achieve a therapeutic effect. Gene therapy techniques are divided into three main categories; viral(including retroviral gene therapy), nonviral, and physical. The use of retroviruses bears a significant advantage over these other forms of gene therapy. Nonviral and physical techniques are less efficient in transfection and, in the case of nonviral vectors, have a more limited expression. Viral techniques, however, are more efficient in transfection and better integrate viral genes into the target genome. [1]
Section 2
<ref>Bartlett et al.: Oncolytcaor viruses as therapeutic cancer vaccines. Molecular Cancer 2013 12:103.<ref>
Section 3
Include some current research, with at least one figure showing data.
Section 4
Conclusion
References
Authored for BIOL 238 Microbiology, taught by Joan Slonczewski, 2022, Kenyon College